Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Notes Payables (2025)

Treace Medical Concepts' Notes Payables history spans 1 years, with the latest figure at $1.7 million for Q4 2025.

  • For Q4 2025, Notes Payables changed N/A year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, changed N/A, while the annual FY2025 figure was $1.7 million, N/A changed from the prior year.
  • Notes Payables reached $1.7 million in Q4 2025 per TMCI's latest filing, down from $1.8 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.8 million in Q3 2025 to a low of $45000.0 in Q1 2025.